24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients

van Leeuwen, DJ; Yee, LJ; Langner, RG; (2002) 24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients. The American journal of gastroenterology, 97 (2). pp. 497-8. ISSN 0002-9270 DOI: https://doi.org/10.1016/S0002-9270(01)04074-6

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar